Dobutamine in Dextrose NDC 0409-0025

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-0025Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-0025Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-0025-10	00409002510	12 POUCH in 1 CASE (0409-0025-10) / 1 BAG in 1 POUCH / 250 mL in 1 BAG (0409-0025-01)Marketed from Mar 16, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dobutamine in Dextrose
Generic name (nonproprietary): dobutamine in dextrose
Active ingredients: Dobutamine hydrochloride — 100 mg/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020201
Marketing start: Mar 16, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Agonists (Mechanism)
Identifiers: Product ID 0409-0025_b02881e1-8e01-4bff-b82e-9d9ec41c7396SPL ID b02881e1-8e01-4bff-b82e-9d9ec41c7396SPL set ID 9943a961-3b50-4847-8a84-d8414ce38daaRxCUI 309985, 309986, 309987UNII 0WR771DJXV
Pharmacologic class: beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409002510 followed by a unit qualifier and the quantity

Package 00409-0025-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 3, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dobutamine in 5% Dextrose Injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. Experience with intravenous dobutamine in controlled trials does not extend beyond 48 hours of repeated boluses and/or continuous infusions. Whether given orally, continuously intravenously, or intermittently intravenously, neither dobutamine nor any other cyclic-AMP-dependent inotrope has been shown in controlled trials to be safe or effective in the long-term treatment of congestive he…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020201

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020201
Product	Strength	Form · route	Labeler	Product NDC
Dobutamine in Dextrose	Dobutamine hydrochloride 400 mg/100mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-1100
Dobutamine In Dextrose	Dobutamine hydrochloride 100 mg/100mL	Injection, SolutionIntravenous	HF Acquisition Co. LLC, DBA HealthFirst	51662-1664
Dobutamine In Dextrose	Dobutamine hydrochloride 100 mg/100mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1697
Dobutamine In Dextrose	Dobutamine hydrochloride 200 mg/100mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1705
Dobutamine in Dextrose	Dobutamine hydrochloride 200 mg/100mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-0151